ADRENALINUM and COVID 19

Overview

COVID 19 is the #6 most commonly reported adverse reaction for ADRENALINUM, manufactured by ARS Pharmaceuticals Operations, Inc.. There are 2,372 FDA adverse event reports linking ADRENALINUM to COVID 19. This represents approximately 2.5% of all 96,806 adverse event reports for this drug.

Patients taking ADRENALINUM who experience covid 19 should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COVID 19 is a less commonly reported adverse event for ADRENALINUM, but still significant enough to appear in the safety profile.

Other Side Effects of ADRENALINUM

In addition to covid 19, the following adverse reactions have been reported for ADRENALINUM:

• DRUG INEFFECTIVE — 4,161 reports
• HEADACHE — 2,845 reports
• SINUSITIS — 2,811 reports
• PRODUCT DOSE OMISSION ISSUE — 2,613 reports
• FATIGUE — 2,560 reports
• PAIN — 2,320 reports
• DYSPNOEA — 2,054 reports
• NAUSEA — 2,035 reports
• PNEUMONIA — 1,941 reports
• OFF LABEL USE — 1,887 reports

Other Drugs Associated with COVID 19

The following drugs have also been linked to covid 19 in FDA adverse event reports:

Does ADRENALINUM cause COVID 19?

COVID 19 has been reported as an adverse event in 2,372 FDA reports for ADRENALINUM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COVID 19 with ADRENALINUM?

COVID 19 accounts for approximately 2.5% of all adverse event reports for ADRENALINUM, making it a notable side effect.

What should I do if I experience COVID 19 while taking ADRENALINUM?

If you experience covid 19 while taking ADRENALINUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages